Gene editing and its applications in biomedicine
G Li, X Li, S Zhuang, L Wang, Y Zhu, Y Chen… - Science China Life …, 2022 - Springer
The steady progress in genome editing, especially genome editing based on the use of
clustered regularly interspaced short palindromic repeats (CRISPR) and programmable …
clustered regularly interspaced short palindromic repeats (CRISPR) and programmable …
The potential revolution of cancer treatment with CRISPR technology
D Stefanoudakis, N Kathuria-Prakash, AW Sun, M Abel… - Cancers, 2023 - mdpi.com
Simple Summary Clustered regularly interspaced short palindromic repeats (CRISPR)-
CRISPR associated protein (Cas) 9 is a novel technology utilized to modify target genes …
CRISPR associated protein (Cas) 9 is a novel technology utilized to modify target genes …
[HTML][HTML] Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells
Y Liao, L Chen, Y Feng, J Shen, Y Gao, G Cote… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Programmed cell death ligand 1 (PD-L1) is a transmembrane protein that is expressed on
tumor cells that suppresses the T cell-mediated immune response. Therapies targeting the …
tumor cells that suppresses the T cell-mediated immune response. Therapies targeting the …
CRISPR-Cas9 technology: applications and human disease modelling
Guest Editors: Lu Xiao-Jie and Ji Li-Juan… - Briefings in …, 2017 - academic.oup.com
Genome engineering is a powerful tool for a wide range of applications in biomedical
research and medicine. The development of the clustered regularly interspaced short …
research and medicine. The development of the clustered regularly interspaced short …
CRISPR-Cas9 technology for the creation of biological avatars capable of modeling and treating pathologies: From discovery to the latest improvements
This is a spectacular moment for genetics to evolve in genome editing, which encompasses
the precise alteration of the cellular DNA sequences within various species. One of the most …
the precise alteration of the cellular DNA sequences within various species. One of the most …
CRISPR/Cas9: the Jedi against the dark empire of diseases
Abstract Advances in Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR
associated system (CRISPR/Cas9) has dramatically reshaped our ability to edit genomes …
associated system (CRISPR/Cas9) has dramatically reshaped our ability to edit genomes …
[HTML][HTML] CRISPR/Cas9, a new approach to successful knockdown of ABCB1/P-glycoprotein and reversal of chemosensitivity in human epithelial ovarian cancer cell …
L Norouzi-Barough, M Sarookhani… - Iranian journal of …, 2018 - ncbi.nlm.nih.gov
Objective (s): Multidrug resistance (MDR) is a major obstacle in the successful
chemotherapy of ovarian cancer. Inhibition of P-glycoprotein (P-gp), a member of ATP …
chemotherapy of ovarian cancer. Inhibition of P-glycoprotein (P-gp), a member of ATP …
An intricate rewiring of cancer metabolism via alternative splicing
G Temaj, S Chichiarelli, S Saha… - Biochemical …, 2023 - Elsevier
All human genes undergo alternative splicing leading to the diversity of the proteins.
However, in some cases, abnormal regulation of alternative splicing can result in diseases …
However, in some cases, abnormal regulation of alternative splicing can result in diseases …
Alternative splicing and cancer metastasis: prognostic and therapeutic applications
DM Marzese, AO Manughian-Peter, JIJ Orozco… - Clinical & experimental …, 2018 - Springer
Metastatic cells exhibit an extraordinary phenotypic plasticity, not only in adapting to
unfamiliar microenvironments but also in surviving aggressive treatments and immune …
unfamiliar microenvironments but also in surviving aggressive treatments and immune …
[HTML][HTML] Deciphering resistance mechanisms and novel strategies to overcome drug resistance in ovarian cancer: a comprehensive review
E Alemzadeh, L Allahqoli, A Mazidimoradi… - Oncology …, 2024 - ncbi.nlm.nih.gov
Ovarian cancer is among the most lethal gynecological cancers, primarily due to the lack of
specific symptoms leading to an advanced-stage diagnosis and resistance to chemotherapy …
specific symptoms leading to an advanced-stage diagnosis and resistance to chemotherapy …